India's Dr Lal Path Labs posts quarterly profit fall on tax expense

Dr. Lal PathLabs

30/04/2026 12:21

Refiles to remove extraneous link in paragraph 1

April 30 (Reuters) - Dr Lal Path Labs DLPA.NS reported a 15.5% drop in fourth-quarter profit on Thursday, hurt by higher tax expenses.

Here are some details:

Consolidated net profit fell to 1.31 billion rupees ($13.8 million) in the quarter ended March, from 1.55 billion rupees a year earlier

Tax expenses stood at 279 million rupees

Dr. Lal, which operates 312 clinical labs across India as of March 31, said consolidated revenue rose 16.6% to 7.03 billion rupees, fueled by strong demand for diagnostic tests

India's largest diagnostics firm by revenue said sample volumes rose 12.9% in the quarter

Demand for medical tests has been supported by a growing focus on preventive healthcare and expansion by diagnostic chains into smaller cities

Analysts at Citi said the company continued to report healthy margins, helped by an improved product mix, cost controls, supply-chain efficiencies and greater use of automation

($1 = 94.9100 Indian rupees)

(Reporting by Mridula Kumar in Bengaluru)

((mridula.kumar@thomsonreuters.com))